false000035291500003529152024-02-272024-02-27

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 27, 2024

 

UNIVERSAL HEALTH SERVICES, INC.

(Exact name of registrant as specified in its charter)

Delaware

1-10765

23-2077891

(State or other jurisdiction of

(Commission

(I.R.S. Employer

Incorporation or Organization)

File Number)

Identification No.)

UNIVERSAL CORPORATE CENTER

367 SOUTH GULPH ROAD

KING OF PRUSSIA, Pennsylvania 19406

(Address of principal executive office) (Zip Code)

Registrant’s telephone number, including area code (610) 768-3300

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class B Common Stock

UHS

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


 

Item 2.02 Results of Operations and Financial Condition

On February 27, 2024, Universal Health Services, Inc. issued the press release attached hereto as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

 

 

 

99.1

Universal Health Services, Inc., press release, dated February 27, 2024.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

Exhibit Index

Exhibit No.

Exhibit

 

 

99.1

Universal Health Services, Inc., press release, dated February 27, 2024.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Universal Health Services, Inc.

 

By:

/s/ Steve Filton

Name: Steve Filton

Title: Executive Vice President and

            Chief Financial Officer

Date: February 27, 2024

 

 

 


Exhibit 99.1

FOR IMMEDIATE RELEASE

February 27, 2024

 

CONTACT:

Steve Filton

 

Chief Financial Officer

 

610-768-3300

 

 

UNIVERSAL HEALTH SERVICES, INC.

ANNOUNCES 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

AND 2024 OPERATING RESULTS FORECAST

Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended December 31, 2023 and 2022:

KING OF PRUSSIA, PA – Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $216.4 million, or $3.16 per diluted share, during the fourth quarter of 2023, as compared to $174.8 million, or $2.43 per diluted share, during the fourth quarter of 2022. Net revenues increased by 7.4% to $3.704 billion during the fourth quarter of 2023, as compared to $3.447 billion during the fourth quarter of 2022.

As reflected on the Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”), our adjusted net income attributable to UHS during the fourth quarter of 2023 was $214.9 million, or $3.13 per diluted share, as compared to $217.1 million, or $3.02 per diluted share, during the fourth quarter of 2022.

Included in our reported and adjusted net income attributable to UHS during the fourth quarter of 2023, were net incremental reimbursements (net of related provider taxes) of approximately $17.8 million, or $.20 per diluted share, recorded in connection with the recently approved Mississippi Hospital Access Program covering the period of July 1, 2023 through December 31, 2023. Included in our reported and adjusted net income attributable to UHS during the fourth quarter of 2022, was an aggregate favorable after-tax impact of approximately $19.6 million, or $.27 per diluted share, recorded in connection with $26.0 million of commercial insurance proceeds received during the quarter in connection with the following: (i) $15.7 million related to a business interruption and property damage claim at one of our behavioral health care facilities, and; (ii) $10.3 million related to a previously incurred information technology incident.

As reflected on the Supplemental Schedule, included in our reported results were unrealized after-tax gains of $1.5 million, or $.03 per diluted share ($1.9 million pre-tax), during the fourth quarter of 2023, and $1.8 million, or $.02 per diluted share ($2.3 million pre-tax) during the fourth quarter of 2022. These unrealized gains, which are included in “Other (income) expense, net”, resulted from increases in the market value of certain equity securities. In addition, as discussed below, included in our reported results during the fourth quarter of 2022 was an unfavorable after-tax impact of $44.1 million, or $.61 per diluted share, resulting from a provision for asset impairment ($57.6 million pre-tax which is included in other operating expenses) recorded to write-down the asset value of an acute care hospital, as discussed below.

As calculated on the attached Supplemental Schedule, our earnings before interest, taxes, depreciation & amortization (“EBITDA net of NCI”, NCI is net income attributable to noncontrolling interests), was $476.9 million during the fourth quarter of 2023, as compared to $419.0 million during the fourth quarter of 2022. Our adjusted earnings before interest, taxes, depreciation & amortization (“Adjusted EBITDA net of NCI”), which excludes the impact of other (income) expense, net, and provision for asset impairment (during the fourth quarter of 2022), was $473.4 million during the fourth quarter of 2023, as compared to $471.7 million during the fourth quarter of 2022.

Consolidated Results of Operations, As Reported and As Adjusted – Twelve-month periods ended December 31, 2023 and 2022:


Reported net income attributable to UHS was $717.8 million, or $10.23 per diluted share, during the full year 2023, as compared to $675.6 million, or $9.14 per diluted share, during 2022. Net revenues increased by 6.6% to $14.282 billion during the full year of 2023, as compared to $13.399 billion during 2022.

As reflected on the Supplemental Schedule, our adjusted net income attributable to UHS during the twelve-month period ended December 31, 2023, was $739.4 million, or $10.54 per diluted share, as compared to $730.2 million, or $9.88 per diluted share, during the twelve-month period ended December 31, 2022.

As reflected on the Supplemental Schedule, included in our reported results were unrealized after-tax losses of $21.6 million, or $.31 per diluted share ($28.2 million pre-tax), during 2023, and $10.6 million, or $.14 per diluted share ($13.8 million pre-tax) during 2022. These unrealized losses, which are included in “Other (income) expense, net”, resulted from decreases in the market value of certain equity securities. In addition, included in our reported results during the full year of 2022 was an unfavorable after-tax impact of $44.1 million, or $.60 per diluted share, resulting from a provision for asset impairment, ($57.6 million pre-tax which is included in other operating expenses), as discussed below.

As calculated on the attached Supplemental Schedule, our earnings before interest, taxes, depreciation & amortization (“EBITDA net of NCI”), was $1.714 billion during 2023, as compared to $1.594 billion during 2022. Our adjusted earnings before interest, taxes, depreciation & amortization (“Adjusted EBITDA net of NCI”), which excludes the impact of other (income) expense, net, and provision for asset impairment (during 2022), was $1.742 billion during 2023, as compared to $1.662 billion during 2022.

Acute Care Services – Three and twelve-month periods ended December 31, 2023 and 2022:

During the fourth quarter of 2023, at our acute care hospitals owned during both periods (“same facility basis”), adjusted admissions (adjusted for outpatient activity) increased by 5.6% while adjusted patient days increased by 4.3%, as compared to the fourth quarter of 2022. At these facilities, during the fourth quarter of 2023, net revenue per adjusted admission increased by 3.7% while net revenue per adjusted patient day increased by 5.0%, as compared to the fourth quarter of 2022. Net revenues generated from our acute care services, on a same facility basis, increased by 9.7% during the fourth quarter of 2023, as compared to the fourth quarter of 2022.

During the twelve-month period ended December 31, 2023, at our acute care hospitals on a same facility basis, adjusted admissions increased by 7.6% while adjusted patient days increased by 4.7%, as compared to the year ended December 31, 2022. At these facilities, during the full year of 2023, net revenue per adjusted admission decreased by 0.6% while net revenue per adjusted patient day increased by 2.2%, as compared to 2022. Net revenues generated from our acute care services, on a same facility basis, increased by 7.6% during the full year of 2023, as compared to 2022.

Behavioral Health Care Services – Three and twelve-month periods ended December 31, 2023 and 2022:

During the fourth quarter of 2023, at our behavioral health care facilities on a same facility basis, adjusted admissions increased by 1.4% while adjusted patient days increased by 1.1%, as compared to the fourth quarter of 2022. At these facilities, during the fourth quarter of 2023, net revenue per adjusted admission increased by 5.8% and net revenue per adjusted patient day increased by 6.1%, as compared to the fourth quarter of 2022. Net revenues generated from our behavioral health care services, on a same facility basis, increased by 7.2% during the fourth quarter of 2023, as compared to the fourth quarter of 2022.

During the twelve-month period ended December 31, 2023, at our behavioral health care facilities on a same facility basis, adjusted admissions increased by 3.2% while adjusted patient days increased by 2.1%, as compared to the comparable period of 2022. At these facilities, during the full year of 2023, net revenue per adjusted admission increased by 4.7% and net revenue per adjusted patient day increased by 5.9%, as compared to 2022. Net revenues generated from our behavioral health care services, on a same facility basis, increased by 8.0% during 2023, as compared to 2022.

Net Cash Provided by Operating Activities and Liquidity:

Net Cash Provided by Operating Activities:

During the twelve-month period ended December 31, 2023, our net cash provided by operating activities was $1.268 billion as compared to $996 million during the full year of 2022. Included in the $272 million net


increase in our net cash provided by operating activities was a favorable change of $114 million in other working capital accounts due primarily to the timing of disbursements for accrued compensation and certain other accrued liabilities, as well as a favorable change of $76 million in accounts receivable.

Liquidity:

As of December 31, 2023, we had $701 million of aggregate available borrowing capacity pursuant to our $1.2 billion revolving credit facility, net of outstanding borrowings and letters of credit.

Stock Repurchase Program:

As of January 1, 2023, we had an aggregate remaining repurchase authorization of approximately $947 million pursuant to our stock repurchase program. Pursuant to the terms of our stock repurchase program, shares of our Class B Common Stock may be repurchased, from time to time as conditions allow, on the open market or in negotiated private transactions.

During the fourth quarter of 2023, we have repurchased 1.13 million shares at an aggregate cost of approximately $157.3 million (approximately $139 per share) pursuant to the program. During the full year of 2023, we have repurchased approximately 3.86 million shares at an aggregate cost of approximately $524.5 million (approximately $136 per share) pursuant to the program.

As of December 31, 2023, we had an aggregate available repurchase authorization of approximately $423 million.

 

2024 Operating Results Forecast:

Reflected below is our 2024 forecasted range for consolidated net revenues, earnings before interest, taxes, depreciation & amortization, and the impacts of other income/expense and net income attributable to noncontrolling interests (“Adjusted EBITDA net of NCI”), net income attributable to UHS per diluted share (“EPS-diluted”) and capital expenditures.

Our 2024 forecasted range of net income attributable to UHS, and EPS-diluted, exclude certain items as described below because we do not believe we can forecast those items with sufficient accuracy. Adjusted EBITDA net of NCI, is a non-GAAP financial measure and should not be considered a measure of financial performance under GAAP. We believe Adjusted EBITDA net of NCI is helpful to our investors as a measure of our operating performance. Please see the Supplemental Non-GAAP Disclosures - 2024 Operating Results Forecast schedule as included herein for additional information and a reconciliation of our 2024 forecasted range of net income attributable to UHS to our 2024 forecasted range of Adjusted EBITDA net of NCI.

For the Year Ended

December 31, 2024

      Low

       High

Net revenues

$15.411 billion

$15.706 billion

Adjusted EBITDA net of NCI

$1.931 billion

$2.019 billion

EPS-diluted

$13.00 per share

$14.00 per share

Capital expenditures

$850 million

$1.000 billion

Our 2024 operating results forecast contains a number of assumptions including, but not limited to, the following:

The 2024 forecasted amounts exclude the impact of future items, if applicable, that are nonrecurring or non-operational in nature including items such as pre-tax unrealized gains/losses resulting from changes in the market value of shares of certain equity securities, and other potential material items including, but not limited to, reserves for various matters including settlements, legal judgments and lawsuits, potential impacts of non-ordinary course acquisitions, divestitures, joint ventures or other strategic transactions, costs related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of goodwill, long-lived and intangible assets, other amounts that may be reflected in the current financial statements that relate to prior periods, and the impact of share repurchases that differ from our forecasted assumptions. It is also subject to certain conditions

including those as set forth below in General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures.
Our net revenues are estimated to be approximately $15.411 billion to $15.706 billion representing an increase of 7.9% to 10.0% over our 2023 net revenues of $14.282 billion.
Our Adjusted EBITDA net of NCI is estimated to be approximately $1.931 billion to $2.019 billion representing an increase of 10.9% to 15.9% over our 2023 Adjusted EBITDA net of NCI of $1.742 billion.
Our EPS-diluted range is estimated to be $13.00 per diluted share to $14.00 per diluted share, representing an increase of 23.3% to 32.8% over our adjusted net income attributable to UHS of $10.54 per diluted share for the year ended December 31, 2023, as calculated on the attached Supplemental Schedule.
Our 2024 operating results forecast includes approximately $158 million of net reimbursements (net of related provider taxes) expected to be earned pursuant to the previously disclosed Nevada State Directed Payment program (“SDP”).
o
The Medicaid managed care component of the Nevada SDP, our annual net reimbursements from which are expected to approximate $140 million during 2024, was approved by the Centers for Medicare and Medicaid Services (“CMS”) in late December, 2023, with an effective date of January 1, 2024. This component of the Nevada SDP requires annual approval by CMS and is subject to reconciliation by Nevada’s Division of Health Care Financing and Policy based on actual Medicaid managed care utilization during 2024. There can be no assurance that the Medicaid managed care component of the Nevada SDP will continue for any period after December 31, 2024, or that it will not be modified.
o
The Medicaid fee for service upper payment limit component of the Nevada SDP, our annual net reimbursements from which are expected to approximate $18 million during 2024, was approved by CMS during the fourth quarter of 2023, with an effective date of July 1, 2023.

Provision for Asset Impairment (recorded during the fourth quarter of 2022):

Our financial statements for the three and twelve-month periods ended December 31, 2022, included a pre-tax provision for asset impairment of $57.6 million, which is included in other operating expenses on the accompanying consolidated statements of income. In March of 2023, we discontinued all inpatient operations at Desert Springs Hospital Medical Center, an acute care facility located in Las Vegas, Nevada. Since that time, we have continued providing emergency department services within a portion of the existing facility while we construct a new free-standing emergency department on the hospital's campus. The provision for asset impairment recorded during the fourth quarter of 2022 reduced the asset values of the facility's real estate and equipment to their estimated fair values.

Conference call information:

We will hold a conference call for investors and analysts at 9:00 a.m. eastern time on February 28, 2024. A live webcast of the call will be available on our website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the call will be available for one full year following the live call.

General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:

One of the nation’s largest and most respected providers of hospital and healthcare services, Universal Health Services, Inc. has built an impressive record of achievement and performance. Growing steadily since our inception into an esteemed Fortune 500 corporation, our annual revenues during 2023 were $14.282 billion. UHS ranked #311 on the Fortune 500; and #434 on Forbes’ list of America’s Largest Public Companies. UHS was again recognized as one of the World’s Most Admired Companies by Fortune.


Our operating philosophy is as effective today as it was upon the Company’s founding in 1979, enabling us to provide compassionate care to our patients and their loved ones. Our strategy includes building or acquiring high quality hospitals in rapidly growing markets, investing in the people and equipment needed to allow each facility to thrive, and becoming the leading healthcare provider in each community we serve.

Headquartered in King of Prussia, PA, UHS has approximately 96,700 employees and, through its subsidiaries, operates 27 inpatient acute care hospitals, 333 inpatient behavioral health facilities, 48 outpatient facilities and ambulatory care access points, an insurance offering, a physician network and various related services located in 39 states, Washington, D.C., the United Kingdom and Puerto Rico. It acts as the advisor to Universal Health Realty Income Trust, a real estate investment trust (NYSE:UHT). For additional information visit www.uhs.com.

This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors, and Item 7-Forward-Looking Statements and Risk Factors, in our Form 10-K for the year ended December 31, 2023), may cause the results to differ materially from those anticipated in the forward-looking statements. These statements are subject to risks and uncertainties and therefore actual results may differ materially. Readers should not place undue reliance on such forward-looking statements which reflect management’s view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Many of the factors that could affect our future results are beyond our control or ability to predict, including, but not limited to:

A significant portion of our revenues are derived from federal and state government programs including the Medicare and Medicaid programs. Payments from these programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review, and federal and state funding restrictions. Changes to these programs, if adopted, could materially affect program payments which could materially impact our results of operations.
The nationwide shortage of nurses and other clinical staff and support personnel experienced by healthcare providers in the past has been a significant operating issue facing us and other healthcare providers. In the past, the staffing shortage has, at times, required us to hire expensive temporary personnel and/or enhance wages and benefits to recruit and retain nurses and other clinical staff and support personnel. At certain facilities, particularly within our behavioral health care segment, there have been occasions when we were unable to fill all vacant positions and, consequently, we were required to limit patient volumes. The staffing shortage has required us to enhance wages and benefits to recruit and retain nurses and other clinical staff and support personnel or required us to hire expensive temporary personnel. Many of these factors, which had a material unfavorable impact on our results of operations during 2022, moderated to a certain degree during 2023.
The increase in interest rates has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms. Additional increases in interest rates could have a significant unfavorable impact on our future results of operations and the resulting effect on the capital markets could adversely affect our ability to carry out our strategy.

We believe that adjusted net income attributable to UHS, adjusted net income attributable to UHS per diluted share, EBITDA net of NCI and Adjusted EBITDA net of NCI, which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect of material items impacting our net income attributable to UHS, such as, changes in the market value of shares of certain equity securities and other potential material items that are nonrecurring or non-operational in nature including, but not limited to, impairments of goodwill, long-lived and intangible assets, reserves for various matters including settlements, legal judgments and lawsuits, costs related to extinguishment of debt, gains/losses on sales of assets and businesses, potential impacts of non-ordinary


acquisitions, divestitures, joint ventures or other strategic transactions, and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. To obtain a complete understanding of our financial performance these measures should be examined in connection with net income attributable to UHS, as determined in accordance with GAAP, and as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2023. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

(more)

 

 

 

Universal Health Services, Inc.

 

Consolidated Statements of Income

 

(in thousands, except per share amounts)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months

 

 

Twelve months

 

 

 

ended December 31,

 

 

ended December 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Net revenues

 

$

3,703,546

 

 

 

3,446,980

 

 

$

14,281,976

 

 

 

13,399,370

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating charges:

 

 

 

 

 

 

 

 

 

 

 

 

Salaries, wages and benefits

 

 

1,799,008

 

 

 

1,701,083

 

 

 

7,107,484

 

 

 

6,762,256

 

Other operating expenses

 

 

998,732

 

 

 

919,673

 

 

 

3,757,216

 

 

 

3,445,733

 

Supplies expense

 

 

393,878

 

 

 

381,936

 

 

 

1,532,828

 

 

 

1,474,339

 

Depreciation and amortization

 

 

145,481

 

 

 

148,353

 

 

 

568,041

 

 

 

581,861

 

Lease and rental expense

 

 

35,251

 

 

 

34,551

 

 

 

141,026

 

 

 

131,626

 

 

 

3,372,350

 

 

 

3,185,596

 

 

 

13,106,595

 

 

 

12,395,815

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from operations

 

 

331,196

 

 

 

261,384

 

 

 

1,175,381

 

 

 

1,003,555

 

Interest expense, net

 

 

53,589

 

 

 

43,887

 

 

 

206,674

 

 

 

126,889

 

Other (income) expense, net

 

 

(3,516

)

 

 

(4,838

)

 

 

28,281

 

 

 

10,406

 

Income before income taxes

 

 

281,123

 

 

 

222,335

 

 

 

940,426

 

 

 

866,260

 

Provision for income taxes

 

 

61,501

 

 

 

51,966

 

 

 

221,119

 

 

 

209,278

 

Net income

 

 

219,622

 

 

 

170,369

 

 

 

719,307

 

 

 

656,982

 

Less: Net income (loss) attributable to noncontrolling interests ("NCI")

 

 

3,244

 

 

 

(4,451

)

 

 

1,512

 

 

 

(18,627

)

Net income attributable to UHS

 

$

216,378

 

 

$

174,820

 

 

$

717,795

 

 

$

675,609

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share attributable to UHS (a)

 

$

3.19

 

 

$

2.45

 

 

$

10.35

 

 

$

9.23

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to UHS (a)

 

$

3.16

 

 

$

2.43

 

 

$

10.23

 

 

$

9.14

 

 

 


Universal Health Services, Inc.

 

Footnotes to Consolidated Statements of Income

 

(in thousands, except per share amounts)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months

 

 

Twelve months

 

 

 

ended December 31,

 

 

ended December 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

(a) Earnings per share calculation:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted:

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to UHS

 

$

216,378

 

 

$

174,820

 

 

$

717,795

 

 

$

675,609

 

Less: Net income attributable to unvested restricted share grants

 

 

(66

)

 

 

(156

)

 

 

(308

)

 

 

(748

)

Net income attributable to UHS - basic and diluted

 

$

216,312

 

 

$

174,664

 

 

$

717,487

 

 

$

674,861

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares - basic

 

 

67,809

 

 

 

71,165

 

 

 

69,321

 

 

 

73,118

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share attributable to UHS:

 

$

3.19

 

 

$

2.45

 

 

$

10.35

 

 

$

9.23

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares

 

 

67,809

 

 

 

71,165

 

 

 

69,321

 

 

 

73,118

 

Add: Other share equivalents

 

 

741

 

 

 

627

 

 

 

804

 

 

 

714

 

Weighted average number of common shares and equiv. - diluted

 

 

68,550

 

 

 

71,792

 

 

 

70,125

 

 

 

73,832

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to UHS:

 

$

3.16

 

 

$

2.43

 

 

$

10.23

 

 

$

9.14

 

 

 


Universal Health Services, Inc.

 

Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")

 

For the Three Months ended December 31, 2023 and 2022

 

(in thousands, except per share amounts)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA/Adjusted EBITDA net of NCI")

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

% Net

 

 

Three months ended

 

 

% Net

 

 

December 31, 2023

 

 

revenues

 

 

December 31, 2022

 

 

revenues

 

Net income attributable to UHS

$

216,378

 

 

 

 

 

$

174,820

 

 

 

 

   Depreciation and amortization

 

145,481

 

 

 

 

 

 

148,353

 

 

 

 

   Interest expense, net

 

53,589

 

 

 

 

 

 

43,887

 

 

 

 

   Provision for income taxes

 

61,501

 

 

 

 

 

 

51,966

 

 

 

 

EBITDA net of NCI

$

476,949

 

 

 

12.9

%

 

$

419,026

 

 

 

12.2

%

Other (income) expense, net

 

(3,516

)

 

 

 

 

 

(4,838

)

 

 

 

Provision for asset impairment

 

-

 

 

 

 

 

 

57,550

 

 

 

 

Adjusted EBITDA net of NCI

$

473,433

 

 

 

12.8

%

 

$

471,738

 

 

 

13.7

%

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

$

3,703,546

 

 

 

 

 

$

3,446,980

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Calculation of Adjusted Net Income Attributable to UHS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

Three months ended

 

 

December 31, 2023

 

 

December 31, 2022

 

 

 

 

 

Per

 

 

 

 

 

Per

 

 

Amount

 

 

Diluted Share

 

 

Amount

 

 

Diluted Share

 

Net income attributable to UHS

$

216,378

 

 

$

3.16

 

 

$

174,820

 

 

$

2.43

 

Plus/minus after-tax adjustments:

 

 

 

 

 

 

 

 

 

 

 

Unrealized gain on equity securities

 

(1,470

)

 

 

(0.03

)

 

 

(1,778

)

 

 

(0.02

)

Provision for asset impairment

 

-

 

 

 

-

 

 

 

44,055

 

 

 

0.61

 

Subtotal adjustments

 

(1,470

)

 

 

(0.03

)

 

 

42,277

 

 

 

0.59

 

Adjusted net income attributable to UHS

$

214,908

 

 

$

3.13

 

 

$

217,097

 

 

$

3.02

 

 


Universal Health Services, Inc.

 

Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")

 

For the Twelve Months ended December 31, 2023 and 2022

 

(in thousands, except per share amounts)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA/Adjusted EBITDA net of NCI")

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Twelve months ended

 

 

% Net

 

 

Twelve months ended

 

 

% Net

 

 

December 31, 2023

 

 

revenues

 

 

December 31, 2022

 

 

revenues

 

Net income attributable to UHS

$

717,795

 

 

 

 

 

$

675,609

 

 

 

 

   Depreciation and amortization

 

568,041

 

 

 

 

 

 

581,861

 

 

 

 

   Interest expense, net

 

206,674

 

 

 

 

 

 

126,889

 

 

 

 

   Provision for income taxes

 

221,119

 

 

 

 

 

 

209,278

 

 

 

 

EBITDA net of NCI

$

1,713,629

 

 

 

12.0

%

 

$

1,593,637

 

 

 

11.9

%

Other (income) expense, net

 

28,281

 

 

 

 

 

 

10,406

 

 

 

 

Provision for asset impairment

 

-

 

 

 

 

 

 

57,550

 

 

 

 

Adjusted EBITDA net of NCI

$

1,741,910

 

 

 

12.2

%

 

$

1,661,593

 

 

 

12.4

%

 

 

 

 

 

 

 

 

 

 

 

 

Net revenues

$

14,281,976

 

 

 

 

 

$

13,399,370

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Calculation of Adjusted Net Income Attributable to UHS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Twelve months ended

 

 

Twelve months ended

 

 

December 31, 2023

 

 

December 31, 2022

 

 

 

 

 

Per

 

 

 

 

 

Per

 

 

Amount

 

 

Diluted Share

 

 

Amount

 

 

Diluted Share

 

Net income attributable to UHS

$

717,795

 

 

$

10.23

 

 

$

675,609

 

 

$

9.14

 

Plus/minus after-tax adjustments:

 

 

 

 

 

 

 

 

 

 

 

Unrealized loss on equity securities

$

21,570

 

 

 

0.31

 

 

 

10,580

 

 

 

0.14

 

Provision for asset impairment

 

-

 

 

 

-

 

 

 

44,055

 

 

 

0.60

 

Subtotal adjustments

 

21,570

 

 

 

0.31

 

 

 

54,635

 

 

 

0.74

 

Adjusted net income attributable to UHS

$

739,365

 

 

$

10.54

 

 

$

730,244

 

 

$

9.88

 

 


Universal Health Services, Inc.

 

Condensed Consolidated Balance Sheets

 

(in thousands)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

December 31,

 

 

 

2023

 

 

2022

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

119,439

 

 

$

102,818

 

Accounts receivable, net

 

 

2,238,265

 

 

 

2,017,722

 

Supplies

 

 

216,988

 

 

 

218,517

 

Other current assets

 

 

236,658

 

 

 

198,283

 

Total current assets

 

 

2,811,350

 

 

 

2,537,340

 

 

 

 

 

 

 

Property and equipment

 

 

11,777,047

 

 

 

11,085,852

 

Less: accumulated depreciation

 

 

(5,652,518

)

 

 

(5,167,394

)

 

 

6,124,529

 

 

 

5,918,458

 

Other assets:

 

 

 

 

 

 

Goodwill

 

 

3,932,407

 

 

 

3,909,456

 

Deferred income taxes

 

 

85,626

 

 

 

68,397

 

Right of use assets-operating leases

 

 

433,962

 

 

 

454,650

 

Deferred charges

 

 

6,974

 

 

 

6,264

 

Other

 

 

572,754

 

 

 

599,623

 

Total Assets

 

$

13,967,602

 

 

$

13,494,188

 

 

 

 

 

 

 

Liabilities and Stockholders' Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Current maturities of long-term debt

 

$

126,686

 

 

$

81,447

 

Accounts payable and other liabilities

 

 

1,813,015

 

 

 

1,760,588

 

Operating lease liabilities

 

 

71,600

 

 

 

67,776

 

Federal and state taxes

 

 

2,046

 

 

 

4,608

 

Total current liabilities

 

 

2,013,347

 

 

 

1,914,419

 

 

 

 

 

 

 

Other noncurrent liabilities

 

 

584,007

 

 

 

487,669

 

Operating lease liabilities noncurrent

 

 

382,559

 

 

 

395,522

 

Long-term debt

 

 

4,785,783

 

 

 

4,726,533

 

 

 

 

 

 

 

Redeemable noncontrolling interest

 

 

5,191

 

 

 

4,695

 

 

 

 

 

 

 

UHS common stockholders' equity

 

 

6,149,001

 

 

 

5,920,582

 

Noncontrolling interest

 

 

47,714

 

 

 

44,768

 

Total equity

 

 

6,196,715

 

 

 

5,965,350

 

 

 

 

 

 

 

Total Liabilities and Stockholders' Equity

 

$

13,967,602

 

 

$

13,494,188

 

 

 


Universal Health Services, Inc.

 

Consolidated Statements of Cash Flows

 

(in thousands)

 

(unaudited)

 

 

Twelve months

 

 

ended December 31,

 

 

2023

 

 

2022

 

Cash Flows from Operating Activities:

 

 

 

 

 

Net income

$

719,307

 

 

$

656,982

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation & amortization

 

568,041

 

 

 

581,861

 

(Gain) loss on sale of assets and businesses

 

(6,250

)

 

 

584

 

Stock-based compensation expense

 

87,720

 

 

 

85,378

 

Provision for asset impairment

 

0

 

 

 

57,550

 

Changes in assets & liabilities, net of effects from acquisitions and dispositions:

 

 

 

 

 

Accounts receivable

 

(182,444

)

 

 

(258,338

)

Accrued interest

 

1,193

 

 

 

1,835

 

Accrued and deferred income taxes

 

(43,450

)

 

 

(29,510

)

Other working capital accounts

 

(32,321

)

 

 

(146,692

)

Medicare accelerated payments and deferred CARES Act and other grants

 

2,978

 

 

 

2,391

 

Other assets and deferred charges

 

48,517

 

 

 

19,918

 

Other

 

39,133

 

 

 

(8,676

)

Accrued insurance expense, net of commercial premiums paid

 

183,462

 

 

 

174,723

 

Payments made in settlement of self-insurance claims

 

(118,089

)

 

 

(141,983

)

Net cash provided by operating activities

 

1,267,797

 

 

 

996,023

 

Cash Flows from Investing Activities:

 

 

 

 

 

Property and equipment additions

 

(743,055

)

 

 

(734,001

)

Proceeds received from sales of assets and businesses

 

24,187

 

 

 

12,001

 

Acquisition of businesses and property

 

(3,728

)

 

 

(20,309

)

(Outflows) inflows from foreign exchange contracts that hedge our net U.K. investment

 

(40,695

)

 

 

94,913

 

Decrease in capital reserves of commercial insurance subsidiary

 

16

 

 

 

100

 

Net cash used in investing activities

 

(763,275

)

 

 

(647,296

)

Cash Flows from Financing Activities:

 

 

 

 

 

Repayments of long-term debt

 

(85,480

)

 

 

(89,367

)

Additional borrowings

 

185,100

 

 

 

705,321

 

Financing costs

 

(308

)

 

 

(3,164

)

Repurchase of common shares

 

(547,363

)

 

 

(832,918

)

Dividends paid

 

(55,480

)

 

 

(58,449

)

Issuance of common stock

 

13,654

 

 

 

14,068

 

Profit distributions to noncontrolling interests

 

(6,830

)

 

 

(5,391

)

(Purchase) sale of ownership interests by (from) minority members

 

2,762

 

 

 

(48,500

)

Net cash used in financing activities

 

(493,945

)

 

 

(318,400

)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

3,056

 

 

 

(8,424

)

Decrease in cash, cash equivalents and restricted cash

 

13,633

 

 

 

21,903

 

Cash, cash equivalents and restricted cash, beginning of period

 

200,837

 

 

 

178,934

 

Cash, cash equivalents and restricted cash, end of period

$

214,470

 

 

$

200,837

 

Supplemental Disclosures of Cash Flow Information:

 

 

 

 

 

Interest paid

$

200,446

 

 

$

120,136

 

Income taxes paid, net of refunds

$

257,896

 

 

$

250,759

 

Noncash purchases of property and equipment

$

66,899

 

 

$

72,064

 

 


Universal Health Services, Inc.

Supplemental Statistical Information

(unaudited)

 

 

 

 

 

 

 

 

 

 

% Change

 

% Change

Same Facility:

 

 

 

 

3 Months ended

 

12 Months ended

 

 

 

 

 

12/31/2023

 

12/31/2023

Acute Care Services

 

 

 

 

 

 

 

Revenues

 

 

 

 

9.7%

 

7.6%

Adjusted Admissions

 

 

 

 

5.6%

 

7.6%

Adjusted Patient Days

 

 

 

 

4.3%

 

4.7%

Revenue Per Adjusted Admission

 

 

 

 

3.7%

 

-0.6%

Revenue Per Adjusted Patient Day

 

 

 

 

5.0%

 

2.2%

 

 

 

 

 

 

 

 

Behavioral Health Care Services

 

 

 

 

 

 

 

Revenues

 

 

 

 

7.2%

 

8.0%

Adjusted Admissions

 

 

 

 

1.4%

 

3.2%

Adjusted Patient Days

 

 

 

 

1.1%

 

2.1%

Revenue Per Adjusted Admission

 

 

 

 

5.8%

 

4.7%

Revenue Per Adjusted Patient Day

 

 

 

 

6.1%

 

5.9%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

UHS Consolidated

Fourth quarter ended

 

Twelve months ended

 

12/31/2023

 

12/31/2022

 

12/31/2023

 

12/31/2022

Revenues

$3,703,546

 

$3,446,980

 

$14,281,976

 

$13,399,370

EBITDA net of NCI

$476,949

 

$419,026

 

$1,713,629

 

$1,593,637

EBITDA Margin net of NCI

12.9%

 

12.2%

 

12.0%

 

11.9%

Adjusted EBITDA net of NCI

$473,433

 

$471,738

 

$1,741,910

 

$1,661,593

Adjusted EBITDA Margin net of NCI

12.8%

 

13.7%

 

12.2%

 

12.4%

 

 

 

 

 

 

 

Cash Flow From Operations

$452,431

 

$297,304

 

$1,267,797

 

$996,023

Capital Expenditures

$206,390

 

$164,446

 

$743,055

 

$734,001

Days Sales Outstanding

 

 

 

 

57

 

55

 

 

 

 

 

 

 

Debt

 

 

 

 

$4,912,469

 

$4,807,980

UHS' Shareholders Equity

 

 

 

 

$6,149,001

 

$5,920,582

Debt / Total Capitalization

 

 

 

 

44.4%

 

44.8%

Debt / EBITDA net of NCI (1)

 

 

 

 

2.87

 

3.02

Debt / Adjusted EBITDA net of NCI (1)

 

 

 

 

2.82

 

2.89

Debt / Cash From Operations (1)

 

 

 

 

3.87

 

4.83

 

 

 

 

 

 

 

 

(1) Latest 4 quarters.

 

 

 

 

 

 

 

 


Universal Health Services, Inc.

Acute Care Hospital Services

For the Three and Twelve Months ended

December 31, 2023 and 2022

(in thousands)

 

Same Facility Basis - Acute Care Hospital Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

Three months ended

 

 

Twelve months ended

 

 

Twelve months ended

 

 

 

December 31, 2023

 

 

December 31, 2022

 

 

December 31, 2023

 

 

December 31, 2022

 

 

 

Amount

 

 

% of Net
Revenues

 

 

Amount

 

 

% of Net
Revenues

 

 

Amount

 

 

% of Net
Revenues

 

 

Amount

 

 

% of Net
Revenues

 

Net revenues

 

$

2,032,535

 

 

 

100.0

%

 

$

1,852,000

 

 

 

100.0

%

 

$

7,840,740

 

 

 

100.0

%

 

$

7,284,868

 

 

 

100.0

%

Operating charges:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Salaries, wages and benefits

 

 

869,942

 

 

 

42.8

%

 

 

812,340

 

 

 

43.9

%

 

 

3,363,213

 

 

 

42.9

%

 

 

3,225,039

 

 

 

44.3

%

Other operating expenses

 

 

559,282

 

 

 

27.5

%

 

 

481,164

 

 

 

26.0

%

 

 

2,144,102

 

 

 

27.3

%

 

 

1,863,414

 

 

 

25.6

%

Supplies expense

 

 

338,790

 

 

 

16.7

%

 

 

321,747

 

 

 

17.4

%

 

 

1,303,018

 

 

 

16.6

%

 

 

1,226,294

 

 

 

16.8

%

Depreciation and amortization

 

 

93,287

 

 

 

4.6

%

 

 

94,919

 

 

 

5.1

%

 

 

358,308

 

 

 

4.6

%

 

 

369,493

 

 

 

5.1

%

Lease and rental expense

 

 

23,930

 

 

 

1.2

%

 

 

23,159

 

 

 

1.3

%

 

 

95,565

 

 

 

1.2

%

 

 

85,915

 

 

 

1.2

%

Subtotal-operating expenses

 

 

1,885,231

 

 

 

92.8

%

 

 

1,733,329

 

 

 

93.6

%

 

 

7,264,206

 

 

 

92.6

%

 

 

6,770,155

 

 

 

92.9

%

Income from operations

 

 

147,304

 

 

 

7.2

%

 

 

118,671

 

 

 

6.4

%

 

 

576,534

 

 

 

7.4

%

 

 

514,713

 

 

 

7.1

%

Interest expense, net

 

 

(643

)

 

 

(0.0

)%

 

 

(241

)

 

 

(0.0

)%

 

 

(2,501

)

 

 

(0.0

)%

 

 

1,109

 

 

 

0.0

%

Other (income) expense, net

 

 

931

 

 

 

0.0

%

 

 

687

 

 

 

0.0

%

 

 

6,099

 

 

 

0.1

%

 

 

1,493

 

 

 

0.0

%

Income before income taxes

 

$

147,016

 

 

 

7.2

%

 

$

118,225

 

 

 

6.4

%

 

$

572,936

 

 

 

7.3

%

 

$

512,111

 

 

 

7.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

All Acute Care Hospital Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

Three months ended

 

 

Twelve months ended

 

 

Twelve months ended

 

 

 

December 31, 2023

 

 

December 31, 2022

 

 

December 31, 2023

 

 

December 31, 2022

 

 

 

Amount

 

 

% of Net
Revenues

 

 

Amount

 

 

% of Net
Revenues

 

 

Amount

 

 

% of Net
Revenues

 

 

Amount

 

 

% of Net
Revenues

 

Net revenues

 

$

2,087,503

 

 

 

100.0

%

 

$

1,939,239

 

 

 

100.0

%

 

$

8,081,402

 

 

 

100.0

%

 

$

7,646,749

 

 

 

100.0

%

Operating charges:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Salaries, wages and benefits

 

 

871,182

 

 

 

41.7

%

 

 

834,647

 

 

 

43.0

%

 

 

3,406,060

 

 

 

42.1

%

 

 

3,332,535

 

 

 

43.6

%

Other operating expenses

 

 

615,810

 

 

 

29.5

%

 

 

596,152

 

 

 

30.7

%

 

 

2,347,560

 

 

 

29.0

%

 

 

2,146,196

 

 

 

28.1

%

Supplies expense

 

 

338,732

 

 

 

16.2

%

 

 

329,129

 

 

 

17.0

%

 

 

1,317,917

 

 

 

16.3

%

 

 

1,264,688

 

 

 

16.5

%

Depreciation and amortization

 

 

93,479

 

 

 

4.5

%

 

 

97,557

 

 

 

5.0

%

 

 

367,644

 

 

 

4.5

%

 

 

383,115

 

 

 

5.0

%

Lease and rental expense

 

 

23,960

 

 

 

1.1

%

 

 

23,330

 

 

 

1.2

%

 

 

96,589

 

 

 

1.2

%

 

 

86,654

 

 

 

1.1

%

Subtotal-operating expenses

 

 

1,943,163

 

 

 

93.1

%

 

 

1,880,815

 

 

 

97.0

%

 

 

7,535,770

 

 

 

93.2

%

 

 

7,213,188

 

 

 

94.3

%

Income from operations

 

 

144,340

 

 

 

6.9

%

 

 

58,424

 

 

 

3.0

%

 

 

545,632

 

 

 

6.8

%

 

 

433,561

 

 

 

5.7

%

Interest expense, net

 

 

(643

)

 

 

(0.0

)%

 

 

(241

)

 

 

(0.0

)%

 

 

(2,501

)

 

 

(0.0

)%

 

 

1,109

 

 

 

0.0

%

Other (income) expense, net

 

 

867

 

 

 

0.0

%

 

 

1,982

 

 

 

0.1

%

 

 

7,788

 

 

 

0.1

%

 

 

2,788

 

 

 

0.0

%

Income before income taxes

 

$

144,116

 

 

 

6.9

%

 

$

56,683

 

 

 

2.9

%

 

$

540,345

 

 

 

6.7

%

 

$

429,664

 

 

 

5.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


We believe that providing our results on a “Same Facility” basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of goodwill, long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Acute Care Hospital Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2023.

 

The All Acute Care Hospital Services table summarizes the results of operations for all our acute care operations during the periods presented. These amounts include: (i) our acute care results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes; (ii) the impact of an asset impairment recorded in the three and twelve months ended December 31, 2022, and; (iv) certain other amounts including the results of facilities acquired or opened during the last twelve months.

 

 


Universal Health Services, Inc.

Behavioral Health Care Services

For the Three and Twelve Months ended

December 31, 2023 and 2022

(in thousands)

 

Same Facility - Behavioral Health Care Services